mDR (SGX:Y3D) was granted an 18-month extension of its waiver from an SGX ruling which governs companies with insufficient operations, according to a Wednesday filing with the Singapore Exchange.
The waiver comes after the Monetary Authority of Singapore indicated that the initial Capital Markets Services license application required a fresh submission, granting the company until December 2027 to complete its diversification into fund management.
Therefore, the SGX granted an extension after assessing the company had taken proactive steps to address MAS's concerns.